CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,610,395 | +30.3% | 176,483 | 0.0% | 0.22% | +34.1% |
| Q1 2023 | $4,304,420 | -22.7% | 176,483 | 0.0% | 0.16% | -21.9% |
| Q4 2022 | $5,566,274 | +11.6% | 176,483 | 0.0% | 0.21% | +2.9% |
| Q3 2022 | $4,987,000 | +113.9% | 176,483 | +100.2% | 0.20% | +121.7% |
| Q2 2022 | $2,331,000 | -9.7% | 88,173 | +19.7% | 0.09% | +1.1% |
| Q1 2022 | $2,580,000 | +94.1% | 73,681 | +79.7% | 0.09% | +111.6% |
| Q4 2021 | $1,329,000 | – | 41,003 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |